Clinical Utility of Genetic Testing in the Precision Diagnosis and Management of Pediatric Patients with Kidney and Urinary Tract Diseases
Open Access
- 28 January 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Kidney360
- Vol. 2 (1) , 90-104
Abstract
Background: As genetic testing increasingly integrates into the practice of nephrology, our understanding of the basis of many kidney disorders has exponentially increased. Given this, we recently initiated a Renal Genetics Clinic (RGC) at our large, urban children’s hospital for patients with kidney disorders. Methods: Genetic testing was performed in Clinical Laboratory Improvement Amendments–certified laboratories using single gene testing, multigene panels, chromosomal microarray, or exome sequencing. Results: A total of 192 patients were evaluated in this clinic, with cystic kidney disease (49/192) being the most common reason for referral, followed by congenital anomalies of the kidney and urinary tract (41/192) and hematuria (38/192). Genetic testing was performed for 158 patients, with an overall diagnostic yield of 81 out of 158 (51%). In the 16 out of 81 (20%) of patients who reached a genetic diagnosis, medical or surgical treatment of the patients were affected, and previous clinical diagnoses were changed to more accurate genetic diagnoses in 12 of 81 (15%) patients. Conclusions: Our genetic testing provided an accurate diagnosis for children and, in some cases, led to further diagnoses in seemingly asymptomatic family members and changes to overall medical management. Genetic testing, as facilitated by such a specialized clinical setting, thus appears to have clear utility in the diagnosis and counseling of patients with a wide range of kidney manifestations.Keywords
All Related Versions
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (K12DK0083014, R01DK078121)
- New York Community Trust (Frederick J. and Theresa Dow Wallace Fund)
- Texas Children's Hospital
- Baylor College of Medicine
- Woods Family Foundation
This publication has 23 references indexed in Scilit:
- Molecular diagnostic experience of whole-exome sequencing in adult patientsGenetics in Medicine, 2015
- Refining Genotype-Phenotype Correlation in Autosomal Dominant Polycystic Kidney DiseaseJournal of the American Society of Nephrology, 2015
- Genomics in the renal clinic - translating nephrogenetics for clinical practiceHuman Genomics, 2015
- A Single-Gene Cause in 29.5% of Cases of Steroid-Resistant Nephrotic SyndromeJournal of the American Society of Nephrology, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Fourteen Monogenic Genes Account for 15% of Nephrolithiasis/NephrocalcinosisJournal of the American Society of Nephrology, 2015
- Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosisKidney International, 2014
- Molecular Findings Among Patients Referred for Clinical Whole-Exome SequencingJAMA, 2014
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney DiseaseNew England Journal of Medicine, 2012
- Comprehensive Molecular Diagnostics in Autosomal Dominant Polycystic Kidney DiseaseJournal of the American Society of Nephrology, 2007